Cargando…

Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation

Systemic sclerosis (SSc; scleroderma) is a multisystem fibrotic disease. The mammalian cleavage factor I 25-kD subunit (CFIm25; encoded by NUDT21) is a key regulator of alternative polyadenylation, and its depletion causes predominantly 3′UTR shortening through loss of stimulation of distal polyaden...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Tingting, Huang, Jingjing, Wagner, Eric J., Ko, Junsuk, Wu, Minghua, Wareing, Nancy E., Xiang, Yu, Chen, Ning-Yuan, Ji, Ping, Molina, Jose G., Volcik, Kelly A., Han, Leng, Mayes, Maureen D., Blackburn, Michael R., Assassi, Shervin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041714/
https://www.ncbi.nlm.nih.gov/pubmed/31757866
http://dx.doi.org/10.1084/jem.20181384
_version_ 1783501193498066944
author Weng, Tingting
Huang, Jingjing
Wagner, Eric J.
Ko, Junsuk
Wu, Minghua
Wareing, Nancy E.
Xiang, Yu
Chen, Ning-Yuan
Ji, Ping
Molina, Jose G.
Volcik, Kelly A.
Han, Leng
Mayes, Maureen D.
Blackburn, Michael R.
Assassi, Shervin
author_facet Weng, Tingting
Huang, Jingjing
Wagner, Eric J.
Ko, Junsuk
Wu, Minghua
Wareing, Nancy E.
Xiang, Yu
Chen, Ning-Yuan
Ji, Ping
Molina, Jose G.
Volcik, Kelly A.
Han, Leng
Mayes, Maureen D.
Blackburn, Michael R.
Assassi, Shervin
author_sort Weng, Tingting
collection PubMed
description Systemic sclerosis (SSc; scleroderma) is a multisystem fibrotic disease. The mammalian cleavage factor I 25-kD subunit (CFIm25; encoded by NUDT21) is a key regulator of alternative polyadenylation, and its depletion causes predominantly 3′UTR shortening through loss of stimulation of distal polyadenylation sites. A shortened 3′UTR will often lack microRNA target sites, resulting in increased mRNA translation due to evasion of microRNA-mediated repression. Herein, we report that CFlm25 is downregulated in SSc skin, primary dermal fibroblasts, and two murine models of dermal fibrosis. Knockdown of CFIm25 in normal skin fibroblasts is sufficient to promote the 3′UTR shortening of key TGFβ-regulated fibrotic genes and enhance their protein expression. Moreover, several of these fibrotic transcripts show 3′UTR shortening in SSc skin. Finally, mice with CFIm25 deletion in fibroblasts show exaggerated skin fibrosis upon bleomycin treatment, and CFIm25 restoration attenuates bleomycin-induced skin fibrosis. Overall, our data link this novel RNA-processing mechanism to dermal fibrosis and SSc pathogenesis.
format Online
Article
Text
id pubmed-7041714
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-70417142020-08-03 Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation Weng, Tingting Huang, Jingjing Wagner, Eric J. Ko, Junsuk Wu, Minghua Wareing, Nancy E. Xiang, Yu Chen, Ning-Yuan Ji, Ping Molina, Jose G. Volcik, Kelly A. Han, Leng Mayes, Maureen D. Blackburn, Michael R. Assassi, Shervin J Exp Med Research Articles Systemic sclerosis (SSc; scleroderma) is a multisystem fibrotic disease. The mammalian cleavage factor I 25-kD subunit (CFIm25; encoded by NUDT21) is a key regulator of alternative polyadenylation, and its depletion causes predominantly 3′UTR shortening through loss of stimulation of distal polyadenylation sites. A shortened 3′UTR will often lack microRNA target sites, resulting in increased mRNA translation due to evasion of microRNA-mediated repression. Herein, we report that CFlm25 is downregulated in SSc skin, primary dermal fibroblasts, and two murine models of dermal fibrosis. Knockdown of CFIm25 in normal skin fibroblasts is sufficient to promote the 3′UTR shortening of key TGFβ-regulated fibrotic genes and enhance their protein expression. Moreover, several of these fibrotic transcripts show 3′UTR shortening in SSc skin. Finally, mice with CFIm25 deletion in fibroblasts show exaggerated skin fibrosis upon bleomycin treatment, and CFIm25 restoration attenuates bleomycin-induced skin fibrosis. Overall, our data link this novel RNA-processing mechanism to dermal fibrosis and SSc pathogenesis. Rockefeller University Press 2019-11-22 /pmc/articles/PMC7041714/ /pubmed/31757866 http://dx.doi.org/10.1084/jem.20181384 Text en © 2019 Weng et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Research Articles
Weng, Tingting
Huang, Jingjing
Wagner, Eric J.
Ko, Junsuk
Wu, Minghua
Wareing, Nancy E.
Xiang, Yu
Chen, Ning-Yuan
Ji, Ping
Molina, Jose G.
Volcik, Kelly A.
Han, Leng
Mayes, Maureen D.
Blackburn, Michael R.
Assassi, Shervin
Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation
title Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation
title_full Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation
title_fullStr Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation
title_full_unstemmed Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation
title_short Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation
title_sort downregulation of cfim25 amplifies dermal fibrosis through alternative polyadenylation
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041714/
https://www.ncbi.nlm.nih.gov/pubmed/31757866
http://dx.doi.org/10.1084/jem.20181384
work_keys_str_mv AT wengtingting downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT huangjingjing downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT wagnerericj downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT kojunsuk downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT wuminghua downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT wareingnancye downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT xiangyu downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT chenningyuan downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT jiping downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT molinajoseg downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT volcikkellya downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT hanleng downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT mayesmaureend downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT blackburnmichaelr downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation
AT assassishervin downregulationofcfim25amplifiesdermalfibrosisthroughalternativepolyadenylation